ClinicalTrials.gg

National Heart, Lung, and Blood Institute (NHLBI): Cardiomyopathy, Hypertrophic trials

The registry lists 23 Cardiomyopathy, Hypertrophic studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 6No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.